Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS).
Caselli C, Di Giorgi N, Ragusa R, Lorenzoni V, Smit J, El Mahdiui M, Buechel RR, Teresinska A, Pizzi MN, Roque A, Poddighe R, Knuuti J, Schütte M, Parodi O, Pelosi G, Scholte A, Rocchiccioli S, Neglia D; SMARTool Investigators. Caselli C, et al. Among authors: di giorgi n. Vascul Pharmacol. 2022 Oct;146:107098. doi: 10.1016/j.vph.2022.107098. Epub 2022 Sep 12. Vascul Pharmacol. 2022. PMID: 36100166
A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome.
Di Giorgi N, Michelucci E, Smit JM, Scholte AJHA, El Mahdiui M, Knuuti J, Buechel RR, Teresinska A, Pizzi MN, Roque A, Poddighe R, Parodi O, Pelosi G, Caselli C, Neglia D, Rocchiccioli S. Di Giorgi N, et al. Atherosclerosis. 2021 Dec;339:1-11. doi: 10.1016/j.atherosclerosis.2021.11.013. Epub 2021 Nov 11. Atherosclerosis. 2021. PMID: 34801858
Blood M2-like Monocyte Polarization Is Associated with Calcific Plaque Phenotype in Stable Coronary Artery Disease: A Sub-Study of SMARTool Clinical Trial.
Sbrana S, Cecchettini A, Bastiani L, Di Giorgi N, Mazzone A, Ceccherini E, Vozzi F, Caselli C, Neglia D, Clemente A, Scholte AJHA, Parodi O, Pelosi G, Rocchiccioli S. Sbrana S, et al. Among authors: di giorgi n. Biomedicines. 2022 Feb 28;10(3):565. doi: 10.3390/biomedicines10030565. Biomedicines. 2022. PMID: 35327367 Free PMC article.
Predictive Added Value of Selected Plasma Lipids to a Re-estimated Minimal Risk Tool.
Bodini A, Michelucci E, Di Giorgi N, Caselli C, Signore G, Neglia D, Smit JM, Scholte AJHA, Mincarone P, Leo CG, Pelosi G, Rocchiccioli S. Bodini A, et al. Among authors: di giorgi n. Front Cardiovasc Med. 2021 Jul 16;8:682785. doi: 10.3389/fcvm.2021.682785. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34336947 Free PMC article.
Biological Effects of Transforming Growth Factor Beta in Human Cholangiocytes.
Ceccherini E, Di Giorgi N, Michelucci E, Signore G, Tedeschi L, Vozzi F, Rocchiccioli S, Cecchettini A. Ceccherini E, et al. Among authors: di giorgi n. Biology (Basel). 2022 Apr 8;11(4):566. doi: 10.3390/biology11040566. Biology (Basel). 2022. PMID: 35453765 Free PMC article.
Plasma Lipidomics and Coronary Plaque Changes: A Substudy of the SMARTool Clinical Trial.
Smit JM, Rocchiccioli S, Signore G, Michelucci E, Di Giorgi N, van Rosendael AR, El Mahdiui M, Neglia D, Knuuti J, Saraste A, Buechel RR, Teresinska A, Pizzi MN, Roque A, Poddighe R, Mertens BJ, Caselli C, Parodi O, Pelosi G, Scholte AJ. Smit JM, et al. Among authors: di giorgi n. Eur Heart J Cardiovasc Imaging. 2024 Mar 6:jeae058. doi: 10.1093/ehjci/jeae058. Online ahead of print. Eur Heart J Cardiovasc Imaging. 2024. PMID: 38445505
12 results